Pharmacologic Tools for Improving Metabolic Health
TLDR Learn about pharmacologic tools like SGLT2 inhibitors, Metformin, and GLP1 agonists that can help improve metabolic health by blocking glucose reabsorption, working as insulin sensitizers, and reducing hemoglobin A1C levels. These drugs not only manage high blood glucose levels but also show promising effects in reducing heart failure risk and improving cardiovascular outcomes.
Timestamped Summary
00:00
The episode discusses pharmacologic tools for improving metabolic health, including SGLT2 inhibitors, Metformin, GLP1 agonists, and the relationship between statins and insulin resistance.
03:29
The episode delves into pharmacological options, including SGLT2 inhibitors, metformin, and GLP1 agonists, for improving metabolic health.
06:43
The kidney selectively filters out substances, reabsorbing only what is needed, presenting an opportunity to prevent the reabsorption of excess glucose through blocking the SGLT2 transporter, a strategy beneficial for managing high blood glucose levels in type two diabetes.
10:05
SGLT2 inhibitors block a protein to prevent glucose reabsorption, while GLP1 agonists work as insulin sensitizers and appetite suppressants, with the development of these drugs stemming from naturally occurring substances like Fluorazine.
13:26
Different drugs like SGLT2 inhibitors and statins have varying structures and potencies, with some being derived from naturally occurring substances, providing a head start for drug development.
16:41
Metformin can significantly reduce hemoglobin A1C levels, potentially transitioning someone from a state of type two diabetes to pre-diabetes.
20:05
SGLT2 inhibitors have shown promising effects beyond glycemic control, including reducing the risk of hospitalization and death for heart failure patients and improving cardiovascular outcomes.
23:12
SGLT2 inhibitors are being explored for their potential geroprotective effects beyond their traditional use in diabetes management.
Categories:
Health & Fitness